Vanguard Capital Management Acquires 5.26% Stake in Organon & Co (OGN)

Vanguard Capital Management LLC filed a Schedule 13G on April 30, 2026, reporting a new ownership stake in Organon & Co (OGN). As of the event date on March 31, 2026, Vanguard beneficially owns 13,717,181 shares of common stock, representing a 5.26% ownership interest in the company. The filing indicates that Vanguard holds sole dispositive power over all 13,717,181 shares, while maintaining sole voting power over 1,980,163 shares. The reported holdings include securities managed by various Vanguard affiliates, including Vanguard Asset Management Limited and Vanguard Global Advisers, LLC. The filing was made under Rule 13d-1(b), certifying that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer. This position represents a significant new institutional entry for Vanguard into Organon & Co, crossing the 5% regulatory threshold.